CSIMarket
 


Atyr Pharma Inc  (LIFE)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
   Industry Biotechnology & Drugs
   Sector  Healthcare

Cumulative Atyr Pharma Inc's Total Debt to Equity for Trailing Twelve Months Period

LIFE's Total Debt to Equity for Trailing Twelve Months Period and Total Debt, Equity growth


Select the Comparisons : Select the Ratio:

LIFE Total Debt to Equity for Trailing Twelve Months Period

(Mar 31 2021)
I. Quarter
(Dec 31 2020)
IV. Quarter
(Sep 30 2020)
III. Quarter
(Jun 30 2020)
II. Quarter
(Mar 31 2020)
I. Quarter
Y / Y Equity Growth 18.03 % 49.74 % 19.68 % 18.9 % 42.33 %
Y / Y Total Debt Growth - - -71.08 % -59.93 % -51.75 %
Total Debt to Equity for Trailing Twelve Months Period 0.05 0.11 0.18 0.25 0.32
Total Ranking # 1132 # 1351 # 1782 # 1504 # 1497
Seq. Equity Growth 57.32 % -1.61 % -10.96 % -14.37 % 99.6 %
Seq. Total Debt Growth - - -38.48 % -27.53 % -21.41 %


Total Debt to Equity for Trailing Twelve Months Period Comment
On the trailing twelve months basis In the I. Quarter Atyr Pharma Inc did not have Total Debt .
Total Debt to Equity for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies in Biotechnology & Drugs industry 46 other companies have achieved lower Total Debt to Equity for Trailing Twelve Months Period than Atyr Pharma Inc. While total ranking remained unchanged compare to previous quarter at no. .

What is Debt to Equity Ratio?
LIFE Charts and Quotes
Total Debt to Equity LIFE in the most recent quarter
Total Debt to Equity for Trailing Twelve Months Period Company Ranking
Within: No.
Industry # 47
Sector # 220
S&P 500 # 1132


Total Debt to Equity for Trailing Twelve Months Period Statistics
High Average Low
0.96 0.32 0
(Sep. 30, 2009)   (Dec. 30, 2015)




Companies with similar average Total Debt to Equity for Trailing Twelve Months Period for 12 months ending Mar 31 2021, within Biotechnology & Drugs Industry Total Debt to Equity for Trailing Twelve Months Period
Orgenesis Inc   0.14 
Tg Therapeutics inc   0.14 
Capricor Therapeutics Inc   0.14 
Ocugen Inc   0.13 
Unity Biotechnology Inc   0.13 
Cv Sciences Inc   0.12 
Syndax Pharmaceuticals Inc   0.12 
Berkeley Lights Inc   0.11 
Eidos Therapeutics Inc   0.10 
Surface Oncology Inc   0.10 
Applied Genetic Technologies Corp  0.10 
Gossamer Bio Inc   0.09 
G1 Therapeutics Inc   0.08 
Eargo Inc   0.08 
Atyr Pharma Inc  0.07 
Scholar Rock Holding Corp  0.07 
Oncocyte Corp  0.07 
Procyon Corp  0.06 
Cannabics Pharmaceuticals Inc   0.06 
Eyenovia Inc   0.06 
Oncotelic Therapeutics Inc   0.05 
Precipio Inc   0.05 
Windtree Therapeutics Inc  0.05 
Frequency Therapeutics Inc   0.04 
Aim Immunotech Inc   0.04 
Obalon Therapeutics Inc  0.04 
C4 Therapeutics Inc   0.04 
Enochian Biosciences Inc  0.03 
Satsuma Pharmaceuticals Inc   0.03 
Quanterix Corp  0.03 


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

APSG's Profile

Stock Price

APSG's Financials

Business Description

Fundamentals

Charts & Quotes

APSG's News

Suppliers

APSG's Competitors

Customers & Markets

Economic Indicators

APSG's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071